Skip to main content
Top
Published in: Virology Journal 1/2018

Open Access 01-12-2018 | Short Report

COS-7-based model: methodological approach to study John Cunningham virus replication cycle

Authors: C. Prezioso, D. Scribano, D. M. Rodio, C. Ambrosi, M. Trancassini, A. T. Palamara, V. Pietropaolo

Published in: Virology Journal | Issue 1/2018

Login to get access

Abstract

John Cunningham virus (JCV) is a human neurotropic polyomavirus whose replication in the Central Nervous System (SNC) induces the fatal demyelinating disease, progressive multifocal leukoencephalopathy (PML). JCV propagation and PML investigation have been severely hampered by the lack of an animal model and cell culture systems to propagate JCV have been very limited in their availability and robustness. We previously confirmed that JCV CY strain efficiently replicated in COS-7 cells as demonstrated by the progressive increase of viral load by quantitative PCR (Q-PCR) during the time of transfection and that archetypal regulatory structure was maintained, although two characteristic point mutations were detected during the viral cycle. This short report is an important extension of our previous efforts in defining our reliable model culture system able to support a productive JCV infection.
Supernatants collected from transfected cells have been used to infect freshly seeded COS-7 cell line. An infectious viral progeny was obtained as confirmed by Western blot and immunofluorescence assay. During infection, the archetype regulatory region was conserved.
Importantly, in this study we developed an improved culture system to obtain a large scale production of JC virus in order to study the genetic features, the biology and the pathogenic mechanisms of JC virus that induce PML.
Literature
1.
go back to reference Padgett BL, Walker DL, Zu Rhein GM, Echroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet. 1971;1:1257–60.CrossRefPubMed Padgett BL, Walker DL, Zu Rhein GM, Echroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet. 1971;1:1257–60.CrossRefPubMed
3.
go back to reference Marshall LJ, Major EO. Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy. J NeuroImmune Pharmacol. 2010;5:404–17.CrossRefPubMedPubMedCentral Marshall LJ, Major EO. Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy. J NeuroImmune Pharmacol. 2010;5:404–17.CrossRefPubMedPubMedCentral
4.
go back to reference Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 1992;5:49–73.CrossRefPubMedPubMedCentral Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 1992;5:49–73.CrossRefPubMedPubMedCentral
5.
go back to reference Hara K, Sugimoto C, Kitamura T, Aoki N, Taguchi F, Yogo Y. Archetype JC virus efficiently replicates in COS-7 cells, simian cells constitutively expressing simian virus 40 T antigen. J Virol. 1998;72:5335–42.PubMedPubMedCentral Hara K, Sugimoto C, Kitamura T, Aoki N, Taguchi F, Yogo Y. Archetype JC virus efficiently replicates in COS-7 cells, simian cells constitutively expressing simian virus 40 T antigen. J Virol. 1998;72:5335–42.PubMedPubMedCentral
6.
go back to reference Nukuzuma S, Kameoka M, Sugiura S, Nakamichi K, Nukuzuma C, Miyoshi I, Takegami T. Archetype JC virus efficiently propagates in kidney-derived cells stably expressing HIV-1 tat. Microbiol Immunol. 2009;53:621–8.CrossRefPubMed Nukuzuma S, Kameoka M, Sugiura S, Nakamichi K, Nukuzuma C, Miyoshi I, Takegami T. Archetype JC virus efficiently propagates in kidney-derived cells stably expressing HIV-1 tat. Microbiol Immunol. 2009;53:621–8.CrossRefPubMed
7.
go back to reference Randhawa P, Zeng G, Bueno M, Salgarkar A, Lesniak A, Isse K, Seyb K, Perry A, Charles I, Hustus C, Huang M, Smith M, Glicksman MA. Inhibition of large T antigen ATPase activity as a potential strategy to develop anti-polyomavirus JC drugs. Antivir Res. 2014;112:113–9.CrossRefPubMed Randhawa P, Zeng G, Bueno M, Salgarkar A, Lesniak A, Isse K, Seyb K, Perry A, Charles I, Hustus C, Huang M, Smith M, Glicksman MA. Inhibition of large T antigen ATPase activity as a potential strategy to develop anti-polyomavirus JC drugs. Antivir Res. 2014;112:113–9.CrossRefPubMed
8.
go back to reference Broekema NM, Imperiale MJ. Efficient propagation of archetype BK and JC polyomaviruses. Virology. 2012;422:235–41.CrossRefPubMed Broekema NM, Imperiale MJ. Efficient propagation of archetype BK and JC polyomaviruses. Virology. 2012;422:235–41.CrossRefPubMed
9.
go back to reference Major EO, Miller AE, Mourrain P, Traub RG, de Widt E, Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc Natl Acad Sci U S A. 1985;82:1257–61.CrossRefPubMedPubMedCentral Major EO, Miller AE, Mourrain P, Traub RG, de Widt E, Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc Natl Acad Sci U S A. 1985;82:1257–61.CrossRefPubMedPubMedCentral
10.
go back to reference Prezioso C, Scribano D, Bellizzi A, Anzivino E, Rodio DM, Trancassini M, Palamara MT, Pietropaolo V. Efficient propagation of archetype JC polyomavirus in COS-7 cells: evaluation of rearrangements within the NCCR structural organization after transfection. Arch Virol. 2017;162:3745–52.CrossRefPubMedPubMedCentral Prezioso C, Scribano D, Bellizzi A, Anzivino E, Rodio DM, Trancassini M, Palamara MT, Pietropaolo V. Efficient propagation of archetype JC polyomavirus in COS-7 cells: evaluation of rearrangements within the NCCR structural organization after transfection. Arch Virol. 2017;162:3745–52.CrossRefPubMedPubMedCentral
11.
go back to reference Delbue S, Branchetti E, Boldorini R, Vago L, Zerbi P, Veggiani C, Tremolada S, Ferrante P. Presence and expression of JCV early gene large T antigen in the brains of immunocompromised and immunocompetent individuals. J Med Virol. 2008;80:2147–52.CrossRefPubMedPubMedCentral Delbue S, Branchetti E, Boldorini R, Vago L, Zerbi P, Veggiani C, Tremolada S, Ferrante P. Presence and expression of JCV early gene large T antigen in the brains of immunocompromised and immunocompetent individuals. J Med Virol. 2008;80:2147–52.CrossRefPubMedPubMedCentral
12.
go back to reference Pietropaolo V, Videtta M, Fioriti D, Mischitelli M, Arancio A, Orsi N, Degener AM. Rearrangement patterns of JC virus noncoding control region from different biological samples. J Neuro-Oncol. 2003;9:603–11. Pietropaolo V, Videtta M, Fioriti D, Mischitelli M, Arancio A, Orsi N, Degener AM. Rearrangement patterns of JC virus noncoding control region from different biological samples. J Neuro-Oncol. 2003;9:603–11.
13.
go back to reference Flaegstad T, Sundsfjord A, Arthur RR, Pedersen M, Traavik T, Subramani S. Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction. Virology. 1991;1991(180):553–60.CrossRef Flaegstad T, Sundsfjord A, Arthur RR, Pedersen M, Traavik T, Subramani S. Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction. Virology. 1991;1991(180):553–60.CrossRef
14.
go back to reference Markowitz RB, Thompson HC, Mueller JF, Cohen JA, Dynan WS. Incidence of BK virus and JC virus viruria in human immunodeficiency virus infected and uninfected subjects. J Infect Dis. 1993;167:13–20.CrossRefPubMed Markowitz RB, Thompson HC, Mueller JF, Cohen JA, Dynan WS. Incidence of BK virus and JC virus viruria in human immunodeficiency virus infected and uninfected subjects. J Infect Dis. 1993;167:13–20.CrossRefPubMed
18.
19.
go back to reference Shishido-Hara Y, Hara Y, Larson T, Yasui K, Nagashima K, Stoner GL. Analysis of capsid formation of human polyomavirus JC (Tokyo-1 strain) by a eukaryotic expression system: splicing of late RNAs, translation and nuclear transport of major capsid protein VP1, and capsid assembly. J Virol. 2000;74:1840–53.CrossRefPubMedPubMedCentral Shishido-Hara Y, Hara Y, Larson T, Yasui K, Nagashima K, Stoner GL. Analysis of capsid formation of human polyomavirus JC (Tokyo-1 strain) by a eukaryotic expression system: splicing of late RNAs, translation and nuclear transport of major capsid protein VP1, and capsid assembly. J Virol. 2000;74:1840–53.CrossRefPubMedPubMedCentral
20.
go back to reference Saribas AS, DeVoto J, Golla A, Wollebo HS, White MK, Safak M. Discovery and characterization of novel trans-spliced products of human polyoma JC virus late transcripts from PML patients. J Cell Physiol. 2017:1–19. https://doi.org/10.1002/jcp.26219. Saribas AS, DeVoto J, Golla A, Wollebo HS, White MK, Safak M. Discovery and characterization of novel trans-spliced products of human polyoma JC virus late transcripts from PML patients. J Cell Physiol. 2017:1–19. https://​doi.​org/​10.​1002/​jcp.​26219.
22.
go back to reference Major EO. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Ann Rev Med. 2010;61:35–47.CrossRefPubMed Major EO. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Ann Rev Med. 2010;61:35–47.CrossRefPubMed
23.
go back to reference Chapagain ML, Nerurkar VR. Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood–brain barrier. J Infect Dis. 2010;202:184–91.CrossRefPubMedPubMedCentral Chapagain ML, Nerurkar VR. Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood–brain barrier. J Infect Dis. 2010;202:184–91.CrossRefPubMedPubMedCentral
24.
25.
go back to reference Agostini HT, Ryschkewitsch CF, Stoner GL. Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals. J Clin Microbiol. 1996;34:159–64.PubMedPubMedCentral Agostini HT, Ryschkewitsch CF, Stoner GL. Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals. J Clin Microbiol. 1996;34:159–64.PubMedPubMedCentral
26.
go back to reference Pietropaolo V, Bellizzi A, Anzivino E, Iannetta M, Zingaropoli MA, Rodio DM, Morreale M, Pontecorvo S, Francia A, Vullo V, Palamara AT, Ciardi MR. Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment. J Neuro-Oncol. 2015;21:653–65. Pietropaolo V, Bellizzi A, Anzivino E, Iannetta M, Zingaropoli MA, Rodio DM, Morreale M, Pontecorvo S, Francia A, Vullo V, Palamara AT, Ciardi MR. Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment. J Neuro-Oncol. 2015;21:653–65.
Metadata
Title
COS-7-based model: methodological approach to study John Cunningham virus replication cycle
Authors
C. Prezioso
D. Scribano
D. M. Rodio
C. Ambrosi
M. Trancassini
A. T. Palamara
V. Pietropaolo
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2018
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-018-0939-1

Other articles of this Issue 1/2018

Virology Journal 1/2018 Go to the issue